IGF2R and Hepatic fibrosis: Based on the results of the cellular uptake of the dimeric IGF2R peptide-modified nanocomplex in HSC-T6 cells, we next examined the biodistribution of the nanocomplexes in rats with CCl4-induced liver fibrosis (Figure 7).